|
1
|
Hirai H and Sherr CJ: Interaction of
D-type cyclins with a novel myb-like transcription factor, DMP1.
Mol Cell Biol. 16:6457–6467. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Inoue K and Sherr CJ: Gene expression and
cell cycle arrest mediated by transcription factor DMP1 is
antagonized by D-type cyclins through a
cyclin-dependent-kinase-independent mechanism. Mol Cell Biol.
18:1590–1600. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Inoue K, Roussel MF and Sherr CJ:
Induction of ARF tumor suppressor gene expression and cell cycle
arrest by transcription factor DMP1. Proc Natl Acad Sci USA.
96:3993–3998. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Inoue K, Wen R, Rehg JE, Adachi M,
Cleveland JL, Roussel MF and Sherr CJ: Disruption of the ARF
transcriptional activator DMP1 facilitates cell immortalization,
Ras transformation, and tumorigenesis. Genes Dev. 14:1797–1809.
2000.PubMed/NCBI
|
|
5
|
Inoue K, Zindy F, Randle DH, Rehg JE and
Sherr CJ: Dmp1 is haplo-insufficient for tumor suppression and
modifies the frequencies of Arf and p53 mutations in Myc-induced
lymphomas. Genes Dev. 15:2934–2939. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fry EA, Taneja P, Maglic D, Zhu S, Sui G
and Inoue K: Dmp1α inhibits HER2/neu-induced mammary tumorigenesis.
PLoS One. 8:e778702013. View Article : Google Scholar
|
|
7
|
Zhu S, Mott RT, Fry EA, Taneja P, Kulik G,
Sui G and Inoue K: Cooperation between Dmp1 loss and cyclin D1
overexpression in breast cancer. Am J Pathol. 183:1339–1350. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Peng Y, Dong W, Lin TX, Zhong GZ, Liao B,
Wang B, Gu P, Huang L, Xie Y, Lu FD, et al: MicroRNA-155 promotes
bladder cancer growth by repressing the tumor suppressor DMTF1.
Oncotarget. 6:16043–16058. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang X, Lou Y, Wang M, Liu C, Liu Y and
Huang W: miR-675 promotes colorectal cancer cell growth dependent
on tumor suppressor DMTF1. Mol Med Rep. 19:1481–1490. 2019.
|
|
10
|
Tian N, Li J, Shi J and Sui G: From
general aberrant alternative splicing in cancers and its
therapeutic application to the discovery of an oncogenic DMTF1
isoform. Int J Mol Sci. 18:1912017. View Article : Google Scholar :
|
|
11
|
Tschan MP, Fischer KM, Fung VS, Pirnia F,
Borner MM, Fey MF, Tobler A and Torbett BE: Alternative splicing of
the human cyclin D-binding Myb-like protein (hDMP1) yields a
truncated protein isoform that alters macrophage differentiation
patterns. J Biol Chem. 278:42750–42760. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Maglic D, Stovall DB, Cline JM, Fry EA,
Mallakin A, Taneja P, Caudell DL, Willingham MC, Sui G and Inoue K:
DMP1β, a splice isoform of the tumour suppressor DMP1 locus,
induces proliferation and progression of breast cancer. J Pathol.
236:90–102. 2015. View Article : Google Scholar :
|
|
13
|
Tschan MP, Federzoni EA, Haimovici A,
Britschgi C, Moser BA, Jin J, Reddy VA, Sheeter DA, Fischer KM, Sun
P and Torbett BE: Human DMTF1β antagonizes DMTF1α regulation of the
p14(ARF) tumor suppressor and promotes cellular proliferation.
Biochim Biophys Acta. 1849:1198–1208. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Niklaus NJ, Humbert M and Tschan MP:
Cisplatin sensitivity in breast cancer cells is associated with
particular DMTF1 splice variant expression. Biochem Biophys Res
Commun. 503:2800–2806. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mallakin A, Sugiyama T, Kai F, Kai F,
Taneja P, Kendig RD, Frazier DP, Maglic D, Matise LA, Willingham MC
and Inoue K: The Arf-inducing transcription factor Dmp1 encodes a
transcriptional activator of amphiregulin, thrombospondin-1, JunB
and Egr1. Int J Cancer. 126:1403–1416. 2010.
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
17
|
Wan M, Huang W, Kute TE, Miller LD, Zhang
Q, Hatcher H, Wang J, Stovall DB, Russell GB, Cao PD, et al Yang
Yin: 1 plays an essential role in breast cancer and negatively
regulates p27. Am J Pathol. 180:2120–2133. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Deng Z, Wan M, Cao P, Rao A, Cramer SD and
Sui G: Yin Yang 1 regulates the transcriptional activity of
androgen receptor. Oncogene. 28:3746–3757. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kosugi S, Hasebe M, Tomita M and Yanagawa
H: Systematic identification of cell cycle-dependent yeast
nucleocytoplasmic shuttling proteins by prediction of composite
motifs. Proc Natl Acad Sci USA. 106:10171–10176. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
la Cour T, Kiemer L, Mølgaard A, Gupta R,
Skriver K and Brunak S: Analysis and prediction of leucine-rich
nuclear export signals. Protein Eng Des Sel. 17:527–536. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ryan M, Wong WC, Brown R, Akbani R, Su X,
Broom B, Melott J and Weinstein J: TCGASpliceSeq a compendium of
alternative mRNA splicing in cancer. Nucleic Acids Res. 44(D1):
D1018–D1022. 2016. View Article : Google Scholar :
|
|
22
|
Martinez RLMC and Naranjo JD: A pretest
for choosing between logrank and Wilcoxon tests in the two-sample
problem. METRON. 68:111–125. 2010. View Article : Google Scholar
|
|
23
|
Baker KE and Parker R: Nonsense-mediated
mRNA decay: Terminating erroneous gene expression. Curr Opin Cell
Biol. 16:293–299. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chang YF, Imam JS and Wilkinson MF: The
nonsense-mediated decay RNA surveillance pathway. Annu Rev Biochem.
76:51–74. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Latchman DS: Inhibitory transcription
factors. Int J Biochem Cell Biol. 28:965–974. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Soutourina J: Transcription regulation by
the Mediator complex. Nat Rev Mol Cell Biol. 19:262–274. 2018.
View Article : Google Scholar
|
|
27
|
Khan MA, Jain VK, Rizwanullah M, Ahmad J
and Jain K: PI3K/AKT/mTOR pathway inhibitors in triple-negative
breast cancer: A review on drug discovery and future challenges.
Drug Discov Today. 24:2181–2191. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Garte SJ: The c-myc oncogene in tumor
progression. Crit Rev Oncog. 4:435–449. 1993.PubMed/NCBI
|
|
29
|
Perrier A, Gligorov J, Lefèvre G and
Boissan M: The extracellular domain of Her2 in serum as a biomarker
of breast cancer. Lab Invest. 98:696–707. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dittmer J: The role of the transcription
factor Ets1 in carcinoma. Semin Cancer Biol. 35:20–38. 2015.
View Article : Google Scholar : PubMed/NCBI
|
